全文获取类型
收费全文 | 1063篇 |
免费 | 67篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 21篇 |
儿科学 | 51篇 |
妇产科学 | 19篇 |
基础医学 | 155篇 |
口腔科学 | 10篇 |
临床医学 | 124篇 |
内科学 | 250篇 |
皮肤病学 | 11篇 |
神经病学 | 89篇 |
特种医学 | 23篇 |
外科学 | 101篇 |
综合类 | 3篇 |
预防医学 | 94篇 |
眼科学 | 17篇 |
药学 | 84篇 |
中国医学 | 1篇 |
肿瘤学 | 79篇 |
出版年
2023年 | 9篇 |
2022年 | 17篇 |
2021年 | 46篇 |
2020年 | 19篇 |
2019年 | 28篇 |
2018年 | 28篇 |
2017年 | 26篇 |
2016年 | 38篇 |
2015年 | 45篇 |
2014年 | 40篇 |
2013年 | 71篇 |
2012年 | 105篇 |
2011年 | 84篇 |
2010年 | 44篇 |
2009年 | 72篇 |
2008年 | 76篇 |
2007年 | 80篇 |
2006年 | 55篇 |
2005年 | 56篇 |
2004年 | 52篇 |
2003年 | 44篇 |
2002年 | 52篇 |
2001年 | 11篇 |
2000年 | 4篇 |
1999年 | 8篇 |
1998年 | 1篇 |
1997年 | 2篇 |
1995年 | 1篇 |
1994年 | 3篇 |
1992年 | 2篇 |
1986年 | 1篇 |
1985年 | 2篇 |
1983年 | 1篇 |
1982年 | 1篇 |
1978年 | 1篇 |
1977年 | 1篇 |
1976年 | 1篇 |
1967年 | 1篇 |
1957年 | 2篇 |
1953年 | 1篇 |
1933年 | 1篇 |
排序方式: 共有1132条查询结果,搜索用时 15 毫秒
51.
52.
53.
54.
Silvana B. Marchioro Rubén Del Pozo Sácristan Annelies Michiels Freddy Haesebrouck Fabricio R. Conceição Odir A. Dellagostin Dominiek Maes 《Vaccine》2014
A recombinant chimaeric protein containing three Mycoplasma hyopneumoniae antigens (C-terminal portion of P97, heat shock protein P42, and NrdF) fused to an adjuvant, the B subunit of heat-labile enterotoxin of Escherichia coli (LTB), was used to immunize pigs against enzootic pneumonia. The systemic and local immune responses, as well as the efficacy of the chimaeric protein in inducing protection against experimental M. hyopneumoniae infection were evaluated. In total, 60 male piglets, purchased from a M. hyopneumoniae-free herd, at 4 weeks of age were randomly allocated to six different experimental groups of 10 animals each: recombinant chimaeric protein by intramuscular (IM) (1) or intranasal (IN) (2) administration, commercial bacterin by IM administration (3), and the adjuvant LTB by IM (4, control group A) or IN (5, control group B) administration. All groups were immunized at 24 and 38 days of age and challenged at 52 days of age. The sixth group that was not challenged was used as the negative control (IN [n = 5] or IM [n = 5] administration of the LTB adjuvant). Compared with the non-challenged group, administration of the chimaeric protein induced significant (P < 0.05) IgG and IgA responses against all individual antigens present in the chimaera, but it could not confer a significant protection against M. hyopneumoniae infection in pigs. This lack of effectiveness points towards the need for further studies to improve the efficacy of this subunit-based vaccine approach. 相似文献
55.
56.
Annelies Müller Jackie Kleynhans Linda de Gouveia Susan Meiring Cheryl Cohen Lucy Jane Hathaway Anne von Gottberg for GERMS-SA 《Emerging infectious diseases》2022,28(1):166
The Streptococcus pneumoniae polysaccharide capsule plays a role in disease severity. We assessed the association of serotype with case-fatality ratio (CFR) in invasive pneumococcal disease (IPD) and meningitis in South Africa, 2012–2018 (vaccine era), using multivariable logistic regression by manual backward elimination. The most common serotypes causing IPD were 8 and 19A. In patients <15 years of age, serotypes associated with increased CFR in IPD, compared with serotype 8 and controlling for confounding factors, were 11A, 13, 19F, 15A, and 6A. None of these serotypes were associated with increased CFR in meningitis. Among IPD patients >15 years of age, serotype 15B/C was associated with increased CFR. Among meningitis patients of all ages, serotype 1 was associated with increased CFR. PCV13 serotypes 1, 3, 6A, 19A, and 19F should be monitored, and serotypes 8, 12F, 15A, and 15B/C should be considered for inclusion in vaccines to reduce deaths caused by S. pneumoniae. 相似文献
57.
58.
Tim Boogaerts Siel Van den Bogaert Laura A. E. Van Poelvoorde Diala El Masri Naomi De Roeck Nancy H. C. Roosens Marie Lesenfants Lies Lahousse Koenraad Van Hoorde Alexander L. N. van Nuijs Peter Delputte 《Viruses》2022,14(3)
Since the beginning of the COVID-19 pandemic, the wastewater-based epidemiology (WBE) of SARS-CoV-2 has been used as a complementary indicator to follow up on the trends in the COVID-19 spread in Belgium and in many other countries. To further develop the use of WBE, a multiplex digital polymerase chain reaction (dPCR) assay was optimized, validated and applied for the measurement of emerging SARS-CoV-2 variants of concern (VOC) in influent wastewater (IWW) samples. Key mutations were targeted in the different VOC strains, including SΔ69/70 deletion, N501Y, SΔ241 and SΔ157. The presented bioanalytical method was able to distinguish between SARS-CoV-2 RNA originating from the wild-type and B.1.1.7, B.1.351 and B.1.617.2 variants. The dPCR assay proved to be sensitive enough to detect low concentrations of SARS-CoV-2 RNA in IWW since the limit of detection of the different targets ranged between 0.3 and 2.9 copies/µL. This developed WBE approach was applied to IWW samples originating from different Belgian locations and was able to monitor spatio-temporal changes in the presence of targeted VOC strains in the investigated communities. The present dPCR assay developments were realized to bring added-value to the current national WBE of COVID-19 by also having the spatio-temporal proportions of the VoC in presence in the wastewaters. 相似文献
59.
60.
Gemma G Kenter Marij J P Welters A Rob P M Valentijn Margriet J G Lowik Dorien M A Berends-van der Meer Annelies P G Vloon Jan W Drijfhout Amon R Wafelman Jaap Oostendorp Gert Jan Fleuren Rienk Offringa Sjoerd H van der Burg Cornelis J M Melief 《Clinical cancer research》2008,14(1):169-177
PURPOSE: To determine the toxicity, safety, and immunogenicity of a human papillomavirus 16 (HPV16) E6 and E7 long peptide vaccine administered to end-stage cervical cancer patients. EXPERIMENTAL DESIGN: Three groups of end-stage cervical cancer patients (in total n = 35) were s.c. vaccinated with HPV16 E6 combined with or separated from HPV16 E7 overlapping long peptides in Montanide ISA-51 adjuvant, four times at 3-week intervals. Group 1 received 300 microg/peptide at a single site and group 2 received 100 microg/peptide of the E6 peptides in one limb and 300 microg/peptide of the E7 peptides in a second limb. Group 3 received separate injections of E6 and E7 peptides, each at a dose of 50 microg/peptide. The primary end point was to determine safety and toxicity of the HPV16 long peptides vaccine. In addition, the vaccine-induced T-cell response was assessed by IFN gamma enzyme-linked immunospot. RESULTS: No toxicity beyond grade 2 was observed during and after four vaccinations. In a few patients, transient flu-like symptoms were observed. Enzyme-linked immunospot analysis of the vaccine-induced immune response revealed that coinjection of the E6 and E7 peptides resulted in a strong and broad T-cell response dominated by immunity against E6. Injection of the E6 and E7 peptides at two different sites increased the E7 response but did not affect the magnitude of the E6-induced immune response. CONCLUSIONS: The HPV16 E6 and E7 long peptide-based vaccine is well tolerated and capable of inducing a broad IFN gamma-associated T-cell response even in end-stage cervical cancer patients. 相似文献